Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infection caused by the SFTS virus. To date, 397 cases of SFTS have been reported in Japan, with a mortality rate of 18.9%. 1
| INTRODUC TI ON
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infection caused by the SFTS virus. To date, 397 cases of SFTS have been reported in Japan, with a mortality rate of 18.9%. 1 The main symptoms of SFTS are fever, liver injury, and thrombocytopenia. 2 However, association of intracranial hemorrhage with SFTS is not well known. Herein, we describe a rare case of SFTS with subdural hematoma.
| C A S E REP ORT
A 79-year-old woman from a rural area of Shimane Prefecture, Japan, developed a fever that worsened until she could neither drink water nor stand 3 days later. She presented at our hospital on day 4 with a fatigued appearance. Her annual health checkup showed no particular abnormalities; she did not use medications. She sometimes encountered deer on her farm. Two years earlier, she had sustained a subdural hematoma in the right occipital region after falling and bruising her head, which disappeared after 2 months without surgery. Her Glasgow Coma Scale (GCS) score was 15/15; following were her vital signs: temperature, 39.3°C; pulse rate, 60 beats/ minute (regular); blood pressure, 131/69 mm Hg; peripheral capillary oxygen saturation, 95%; and respiratory rate, 22 breaths/minute. Although her fever resolved after day 7, she became stuporous 4 and mostly slept except during meal times (GCS score, 14 points = E3V5M6). On day 8, serological Rickettsia examination yielded negative findings. On day 9, an SFTS polymerase chain reaction test yielded positive results (viral RNA load, 1.4 × 10 6 copies/ mL); 5 thus, we diagnosed SFTS. She received blood platelets (10 units) following a decrease in platelet count to 17 000/μL. We also diagnosed atrial fibrillation, which did not disappear until day 10; thus, we initiated oral rivaroxaban (10 mg/day).
On day 11, she became deeply stuporous (GCS, 11 points = E3V3M5). 4 She responded affirmatively to all questions but determining whether she was in pain was difficult. She had no other visible symptoms (eg, quadriplegia, facial paralysis, anisocoria). Head magnetic resonance imaging showed a small subdural hematoma in the same right occipital site where a hematoma had developed 2 years earlier ( Figure 1A) . Her atrial fibrillation disappeared on day 11, and rivaroxaban was stopped.
After day 12, her AST, ALT, and lactate dehydrogenase (LDH) levels began to decrease. On day 14, her consciousness improved to drowsiness (GCS, 14 points = E4V4M6); 4 on day 19, plain head CT confirmed no increase in the subdural hematoma ( Figure 1B) . She was discharged without sequelae on day 47. Figure 2 shows her clinical course. In our case, we supposed that the subdural hematoma did not expand because it involved venous microbleeding rather than arterial bleeding. 10 
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